SCHEMBL2597710

SCHEMBL2597710

CC(CCN1CCNCC1)OC(=O)CN

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRM5 P08912 1/20 0.40
▸ CHRM3 P20309 1/20 0.40
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ PADI1 Q9ULC6 1/20 0.36
▸ PADI4 Q9UM07 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ANPEP P15144 1/20 0.35
▸ ERAP2 Q6P179 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.33
▸ HTR4 Q13639 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ HRH2 P25021 1/20 0.32
▸ HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8693562 0.76 CHRM5 (0.38) CHRM5CHRM3SMN1; SMN2SIGMAR1
SCHEMBL19156830 0.74 FAAH (0.45) CHRM5CHRM3SIGMAR1ALDH1A1HRH2
SCHEMBL8693568 0.72 MEN1 (0.42) MEN1KMT2ASMN1; SMN2SIGMAR1ALDH1A1
SCHEMBL6603994 0.71 CHRM5 (0.44) CHRM5CHRM3MEN1KMT2ASMN1; SMN2
SCHEMBL9801548 0.70 SMN1; SMN2 (0.46) CHRM5CHRM3MEN1KMT2APADI1
SCHEMBL22320733 0.70 SMN1; SMN2 (0.46) CHRM5CHRM3MEN1KMT2APADI1
SCHEMBL27438939 0.70 CHRM5 (0.46) CHRM5CHRM3MEN1KMT2APADI1
SCHEMBL561818 0.70 HRH2 (0.44) MEN1KMT2ASMN1; SMN2ALDH1A1HRH2
Alcohol SCHEMBL7951329 0.70 SMN1; SMN2 (0.37) CHRM5CHRM3MEN1KMT2APADI1
SCHEMBL19443244 0.69 FAAH (0.42) CHRM5CHRM3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3047274-A2 PSA ENZYMATIC ACTIVITY: A NEW BIOMARKER FOR ASSESSING PROSTATE CANCER AGGRESSIVENESS Ohmx Corporation (US) 2016-07-27 — — EP disclosed
WO-2015042493-A2 PSA ENZYMATIC ACTIVITY: A NEW BIOMARKER FOR ASSESSING PROSTATE CANCER AGGRESSIVENESS OHMX CORPORATION (US) 2015-03-26 — — WO disclosed
EP-2571997-A2 ENZYMATIC ACTIVITY OF PSA AS DIAGNOSTIC MARKER FOR PROSTATE CANCER Ohmx Corporation (US) 2013-03-27 — — EP disclosed
WO-2011146143-A2 DETECTION OF CANCER BY ASSAYING PSA ENZYMATIC ACTIVITY OHMX CORPORATION (US) 2011-11-24 — — WO disclosed
Send feedback